BDO Releases 2022/2023 CRO Insights Report
Employee turnover continues to impact the global market for talent in Clinical Research Organizations. The companies that will be successful in not only retaining top talent but also in recruiting will employ innovative approaches to their reward strategies.
This Insights Report is based on results from the recently published BDO CRO Industry Global Compensation & Turnover Survey. This Insights Report discusses how now, more than ever, companies are digging deep to find ways to make sure employees stay, which is stirring the buzz term “The Great Retention.” A few key topics covered in this Insights Report include:
- The talent shortage exacerbates high turnover and results in shortened tenure
- The influence of salary increases on turnover
- Career opportunities help combat the turnover challenge
- Attraction and retention in times of economic uncertainty
BDO’s annual CRO Industry Global Compensation & Turnover Survey collects data for 268 positions in the US and 55 countries outside of the US. This survey is designed to help clinical research outsourcing companies develop confidence in their pay levels by providing data necessary to gain insight into their compensation practices relative to the market.
Download the report here.
Reference
2022/2023 Clinical Research Organization Compensation & Turnover Insights Report. (2023, January 24). BDO.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
